Frailty as a marker of adverse outcomes during cystectomy for urothelial cancer

被引：1
|
作者：
Kates, Max
Patel, Hiten
Sopko, Nikolai
Liu, Jeri-Jane
Pierorazio, Phillip M.
Bivalacqua, Trinity
机构：
[1] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ Hosp, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, James Buchanan Brady Urol Inst, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.374
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
374
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Upper Urinary Tract Urothelial Cancer After Radical Cystectomy for Bladder Cancer: Survival Outcomes After Radical Nephroureterectomy
    Slusarczyk, Aleksander
    Zapala, Piotr
    Piecha, Tomasz
    Zapala, Lukasz
    Borkowski, Tomasz
    Radziszewski, Piotr
    ANNALS OF SURGICAL ONCOLOGY, 2023, 31 (3) : 2144 - 2153
  • [42] Frailty Index, Not Age, Predicts Treatment Outcomes and Adverse Events for Older Adults with Cancer
    Fletcher, J.
    Reid, N.
    Hubbard, R. E.
    Berry, R.
    Weston, M.
    Walpole, E.
    Kimberley, R.
    Thaker, D. A.
    Ladwa, R.
    JOURNAL OF FRAILTY & AGING, 2024, 13 (04): : 487 - 494
  • [43] Relation between frailty and adverse outcomes in elderly patients with gastric cancer: a scoping review
    Tan, Zheng-Ke-Ke
    Tang, Wen-Zhen
    Jia, Kui
    Li, Dan-Ni
    Qiu, Li-Yan
    Chen, Xin
    Yang, Li
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (03): : 1590 - 1600
  • [44] Hypoglycemia and Adverse Outcomes: Marker or Mediator?
    Lipska, Kasia J.
    Kosiborod, Mikhail
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2011, 12 (03) : 132 - 135
  • [45] Bcl-2 as a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy
    Turker, Polat
    Hemdan, Tammer
    Segersten, Ulrika
    Malmstrom, Per-Uno
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 620 - 620
  • [46] Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy?
    Turker, Polat
    Segersten, Ulrika
    Malmstrom, Per-Uno
    Hemdan, Tammer
    SCANDINAVIAN JOURNAL OF UROLOGY, 2019, 53 (01) : 45 - 50
  • [47] Clinical outcomes of urothelial carcinoma of the prostate detected in radical cystectomy specimens
    Ichihara, Koji
    Masumori, Naoya
    Kitamura, Hiroshi
    Hasegawa, Tadashi
    Tsukamoto, Taiji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (01) : 152 - 156
  • [48] Outcomes of radical cystectomy for micropapillary urothelial carcinoma at the University of Southern California
    Fairey, Adrian Stuart
    Daneshmand, Siamak
    Schuckman, Anne
    Leiskovsky, Gary
    Djaladat, Hooman
    Cai, Jie
    Miranda, Gus
    Skinner, Eila C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [49] Association between frailty as assessed by the electronic frailty index and adverse postoperative outcomes
    Narganes, D.
    Drayton, D. J.
    McMenamin, L.
    Maclaine, T. D.
    Wong, D.
    Bates, C.
    Kotze, A.
    Howell, S. J.
    BRITISH JOURNAL OF ANAESTHESIA, 2018, 121 (02) : E17 - E18
  • [50] Frailty defined by the SHARE Frailty Instrument and adverse outcomes after an ED visit
    Stiffler, Kirk A.
    Wilber, Scott T.
    Frey, Jennifer
    McQuown, Colleen M.
    Poland, Scott
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (12): : 2443 - 2445
12345